Research

The study has appeared online in "The Lancet Infectious Diseases"

The study evaluating Tiragolumab plus Tecentriq did not meet its co-primary endpoint of progression-free survival

CEPI will fund the researchers to conduct activities including immunogen design, pre-clinical studies, manufacturing process…

The vaccine, based on messenger RNA (mRNA) technology, is one of the most widely used worldwide against COVID, but has yet to…

The research, published in the journal "Science Translational Medicine," demonstrates the potential of the vaccine to work through…

The study is likely to be conducted at six sites, including AIIMS Delhi and Patna

Centre to develop small molecules, innovative formulations and APIs for global markets

Researchers found that the molecule PK2 not only increases insulin release, but also prevents and reverses beta cell loss, making…

With the announcement, Abogen joins Pfizer/BioNTech and Moderna in trialling candidates modified specifically against Omicron

The FDA had put Pfizer's trial request on hold after the death of a patient in another early-stage study of the therapy for…